Holen Sie sich die Stockscreener-App
34.51
3.63%
1.21
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
Castle Biosciences CEO Derek Maetzold sells $462,567 in stock - Investing.com
Castle Biosciences CEO Derek Maetzold sells $462,567 in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc: Derek J. Maetzold (Director, Pres. & Chief Exec. Officer) For: 19 October - Investing.com Nigeria
Form 144 Castle Biosciences For: 17 October By Investing.com - Investing.com Nigeria
Castle Biosciences CCO Tobin sells $110,608 in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc: Tobin W. Juvenal (Chief Commercial Officer) For: 12 October - Investing.com Nigeria
Castle Biosciences CCO Tobin sells $110,608 in stock - Investing.com
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 3,288 Shares - GuruFocus
Castle Biosciences CCO Tobin Juvenal Files to Sell 13,154 Shares in October 2026 - Kalkine Media
The chief commercial officer proposes selling 13,154 Castle Biosciences (CSTL) shares. - Stock Titan
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com South Africa
Castle Biosciences president and CEO Derek Maetzold sells $515k stock - Investing.com
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com Nigeria
Castle Biosciences, Inc. (NASDAQ:CSTL) Stock Has Consensus Target Price of $42.00 According to Brokerages - MarketBeat
Castle Biosciences CEO Derek Maetzold Executes Option Exercise and Sells 14,496 Shares on October 5, 2026 - Kalkine Media
Castle Biosciences Officer Derek Maetzold Files Form 144 for 28,992 Share Sale Valued Over $1 Million - Kalkine Media
An officer and two trusts propose selling 28,992 shares of Castle Biosciences (CSTL). - Stock Titan
Castle Biosciences COO Kristen M. Oelschlager Exercises Stock Options and Sells Shares Under Rule 10b5-1 Plan - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,577 Shares - GuruFocus
Castle Biosciences CCO Executes 6,577-Share Sale Under Rule 10b5-1 Plan - Kalkine Media
Officer Kristen Oelschlager proposes selling 4,153 Castle Biosciences (CSTL) shares. - stocktitan.net
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com UK
Castle Biosciences CEO sells $512k in stock - Investing.com
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Castle Biosciences CEO sells $512k in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com India
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen - marketbeat.com
How Investors May Respond To Castle Biosciences Stock After New Test Validation Studies - simplywall.st
Castle Biosciences (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W Sells 6,600 Shares Between $32.32 and $35.14 - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,600 Shares - GuruFocus
6,600 Castle Biosciences (CSTL) shares sold under preset 10b5-1 plan - Stock Titan
Castle Biosciences (CSTL) CCO plans more stock sales under 10b5-1 plan - Stock Titan
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Preset sale plan at Castle Biosciences (CSTL) covers 29K shares - Stock Titan
Castle Biosciences, Inc.JAAD Publication Shows Improved Performance of DecisionDx-SCC - marketscreener.com
Responsive Playbooks and the CSTL Inflection - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Price Quote Today & Current Price Chart - Capital.com
JAAD Publication Shows Improved Performance of DecisionDx®-SCC - AdVantageNews.com
CSTL Looks 8.4% Overvalued on GF Value™ - GuruFocus
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com India
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com UK
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
1.23%
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):